The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1424-1430 , June 2010

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer

  • Walter Weder, MD

      Affiliations

    • Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • Corresponding Author InformationAddress for reprints: Walter Weder, MD, Head, Division of Thoracic Surgery, University Hospital Zurich, Rämistrasse 100, CH-8091 Zürich.
    • Both authors contributed equally to this work.
    • ,
  • Stéphane Collaud, MD

      Affiliations

    • Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • Both authors contributed equally to this work.
    • ,
  • Wilfried E.E. Eberhardt, MD

      Affiliations

    • Department of Internal Medicine, West German Cancer Center, University of Duisburg-Essen, Essen, Germany
    • ,
  • Sven Hillinger, MD

      Affiliations

    • Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Stefan Welter, MD

      Affiliations

    • Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen-Heidhausen, Germany
    • ,
  • Rolf Stahel, MD

      Affiliations

    • Clinic and Policlinic of Oncology, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Georgios Stamatis, MD

      Affiliations

    • Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, Essen-Heidhausen, Germany

Received 13 May 2009 ,Revised 27 January 2010 ,Accepted 20 February 2010.

References 

  1. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canot A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med. 1994;330:153–158
  2. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst. 1994;86:673–680
  3. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg. 2001;72:1149–1154
  4. Gudbjartsson T, Gyllstedt E, Pikwer A, Jönsson P. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann Thorac Surg. 2008;86:376–382
  5. Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small cell lung cancer. Ann Thorac Surg. 2004;78:1200–1205
  6. Deutsch M, Crawford J, Leopold K, Wolfe W, Foster W, Herndon J, et al. Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer. 1994;74:1243–1252
  7. Fowler WC, Langer CJ, Curran WJ, Keller SM. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg. 1993;55:986–989
  8. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18:1059–1068
  9. Lardinois D, De Leyn P, Van Schil P, Rami-Porta R, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node stating in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30:787–792
  10. Van Meerbeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Natl Cancer Inst. 2007;99:442–450
  11. Perrot E, Guibert B, Mulsant P, Blandin S, Arnaud I, Roy P, et al. Preoperative chemotherapy does not increase complications after non-small cell lung cancer resection. Ann Thorac Surg. 2005;80:423–427
  12. Daly BD, Fernando HC, Ketchedjian A, Dipetrillo TA, Kachnic LA, Morelli DM, et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for non-small cell lung cancer. Ann Thorac Surg. 2006;82:227–231
  13. Alexiou C, Beggs D, Rogers ML, Beggs L, Asopa S, Salama FD. Pneumonectomy for non-small cell lung cancer: predictors of mortality and survival. Eur J Cardiothorac Surg. 2001;20:476–480
  14. Albain KS, Swann RS, Rusch VR, Turrisi AT, Shepherd FA, Smith CJ, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomized controlled trial. Lancet. 2009;374:379–386
  15. Licker M, Spiliopoulos A, Frey JG, Robert J, Höhn L, de Perrot M, et al. Risk factor for early mortality and major complications following pneumonectomy for non-small cell lung carcinoma of the lung. Chest. 2002;121:1890–1897
  16. Van Raemdonck DE, Schneider A, Ginsberg RJ. Surgical treatment for higher stage non-small cell lung cancer. Ann Thorac Surg. 1992;54:999–1013
  17. Stamatis G. Risks of neoadjuvant chemotherapy and radiation therapy. Thorac Surg Clin. 2008;18:71–80
  18. Mansour Z, Kochetkova EA, Ducrocq X, Vasilescu MD, Maxant G, Buggenhout A, et al. Induction chemotherapy does not increase the operative risk of pneumonectomy. Eur J Cardiothorac Surg. 2007;32:181–185
  19. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol. 1998;16:622–634
  20. Stamatis G, Eberhardt W, Pöttgen C. Surgery after multimodality treatment for non-small cell lung cancer. Lung Cancer. 2004;45(Suppl 2):107–112
  21. Van Schil P, Van Meerbeeck J, Kramer G, Splinter T, Legrand C, Giaccone G, et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J. 2005;26:192–197
  22. DeCamp MM, Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, Murthy SC, et al. Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:17–27
  23. Doddoli C, Thomas P, Thirion X, Serée Y, Giudicelli R, Fuentes P. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg. 2001;20:385–390
  24. Stamatis G, Djuric D, Eberhardt W, Pöttken C, Zaboura G, Fechner S, et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg. 2002;22:292–297
  25. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;27(349):2117–2127

 Disclosures: None.

PII: S0022-5223(10)00223-0

doi: 10.1016/j.jtcvs.2010.02.039

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1424-1430 , June 2010

Article Tools

* Image Usage & Resolution